--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
CA Stock MarketDetailed Quotes
ATE Antibe Therapeutics Inc
- 0.295
- 0.0000.00%
15min DelayMarket Closed Apr 10 09:30 ET
15.64MMarket Cap-842P/E (TTM)
0.000High0.000Low0Volume0.000Open0.295Pre Close0.00Turnover1.23052wk High0.00%Turnover Ratio53.01MShares0.15052wk Low-0.35EPS TTM15.10MFloat Cap8.900Historical HighLossP/E (Static)51.20MShs Float0.150Historical Low-0.37EPS LYR0.00%Amplitude--Dividend TTM0.60P/B1Lot Size--Div YieldTTM
Antibe Therapeutics Inc Key Stats
Antibe Therapeutics Inc Earnings Date
Currency: CAD
Period
Q3 FY2024 Earnings
--
Revenue(YoY)
0.00
0.00%EPS(YoY)
-0.08
0.00%Antibe Therapeutics Inc Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: CAD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Heat List
CA
Overall
Symbol
Latest Price
%Chg